Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study
Medicine Bulletin · 2025
DOI: 10.1002/mdb2.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine Bulletin, 2025. Verfasst von Jun Yu und 9 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
To evaluate the associations of systemic diseases with AMD incidence and explore whether polygenic risk score (PRS) for AMD influences these associations. To assess the impacts of polymorbidities and serum biomarkers on AMD risk.
Methods
This prospective study of 471156 AMD‐free UK Biobank participants assessed systemic diseases (hypertension, diabetes, cardiovascular disease [CVD], dyslipidemia, chronic kidney disease [CKD], and dementia) and AMD incidence using multivariable Cox proportional hazard models.
Results
Five systemic diseases were associated with an increased risk of AMD incidence, including hypertension (fully adjusted HR = 1.13, 95% CI: 1.09–1.18; false discovery rate [FDR]‐corrected p = 3.41 × 10 −8 ), diabetes (HR = 1.48, 95% CI: 1.38–1.58; p = 3.79 × 10 −27 ), CVD (HR = 1.13, 95% CI: 1.08–1.18; p = 7.60 × 10 −8 ), dyslipidemia (HR = 1.11, 95% CI: 1.05–1.16; p = 1.28 × 10 −4 ), and CKD (HR = 1.22, 95% CI: 1.07–1.39; p = 0.006), whereas dementia showed no association ( p = 0.74). AMD PRS modified the association with diabetes, but not with the other diseases. The risk of AMD incidence increased in participants with one to five comorbidities ( p for trends < 0.001), compared to those without. Serum biomarkers related to lipid regulation, inflammation, glycemic control, renal function, and nutrition were associated with AMD incidence.
Conclusions
Major systemic diseases elevate AMD risk, compounded by comorbidities. Serum biomarkers further implicate systemic health in AMD. Holistic health management and regular ocular screenings are crucial for AMD patients and those with systemic diseases.
Zitieren
APA
Yu, J., Zhang, Y., Ho, M., Kam, K. W., Rong, S. S., Young, A. L., Pang, C. P., Tham, C. C., Yam, J. C., & Chen, L. J. (2025). Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study. Medicine Bulletin. https://doi.org/10.1002/mdb2.70008
Vancouver
Yu J, Zhang Y, Ho M, Kam KW, Rong SS, Young AL, et al. Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study. Medicine Bulletin. 2025. doi:10.1002/mdb2.70008
BibTeX
@article{Yu2025,
author = {Yu, Jun and Zhang, Yuzhou and Ho, Mary and Kam, Ka Wai and Rong, Shi Song and Young, Alvin L. and Pang, Chi Pui and Tham, Clement C. and Yam, Jason C. and Chen, Li Jia},
title = {Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age‐Related Macular Degeneration: The UK Biobank Study},
journal = {Medicine Bulletin},
year = {2025},
doi = {10.1002/mdb2.70008}
}
EUVIMED